<table border="1" cellpadding="2" cellspacing="0" frame="box" id="table_7" rules="all" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<colgroup>
<col width="14*"></col>
<col width="14*"></col>
<col width="14*"></col>
<col width="5*"></col>
<col width="17*"></col>
<col width="17*"></col>
<col width="17*"></col>
</colgroup>
<tfoot>
<tr>
<td colspan="7" stylecode="Toprule Lrule">1   Ritonavir and indinavir were co-administered for 15 days; Day 14 doses were administered after a 15%-fat breakfast (757 Kcal) and 9%-fat evening snack (236 Kcal), and Day 15 doses were administered after a 15%-fat breakfast (757 Kcal) and 32%-fat dinner (815 Kcal). Indinavir C<sub>min</sub> was also increased 4-fold. Effects were assessed relative to an indinavir 800 mg q8h regimen under fasting conditions.<br/>2   Effects were assessed on a dose-normalized comparison to a methadone 20 mg single dose.<br/>3  Sulfamethoxazole and trimethoprim taken as single combination tablet.<br/>4   90% CI presented for R- and S-warfarin AUC and C<sub>max</sub> ratios.<br/>5   This significant increase in plasma fluticasone propionate exposure resulted in a significant decrease (86%) in plasma cortisol AUC.<br/>6    For the reference arm: N=14 for C<sub>max</sub> and AUC<sub>(0-inf),</sub> and for the test arm: N=13 for C<sub>max</sub> and N=4 for AUC<sub>(0-inf).</sub>
<br/>7    90% CI presented for rivaroxaban<br/>8   90% CI presented for simeprevir (change in exposure presented as percentage increase)<br/>↑   Indicates increase.<br/>↓  Indicates decrease.<br/>↔  Indicates no change.<br/>*   Parallel group design; entries are subjects receiving combination and control regimens, respectively. </td>
</tr>
</tfoot>
<tbody>
<tr>
<td align="center" colspan="7" stylecode="Toprule Lrule">
<content stylecode="bold">Table 7. Drug Interactions - Pharmacokinetic Parameters for Co-administered Drug in the Presence of NORVIR </content>
</td>
</tr>
<tr valign="top">
<td stylecode="Toprule Lrule">
<content stylecode="bold">Co-administered Drug</content>
</td>
<td stylecode="Toprule Lrule">
<content stylecode="bold">Dose of Co-administered Drug</content>
<br/>
<content stylecode="bold">(mg)</content>
</td>
<td stylecode="Toprule Lrule">
<content stylecode="bold">Dose of NORVIR </content>
<br/>
<content stylecode="bold">(mg)</content>
</td>
<td stylecode="Toprule Lrule">
<content stylecode="bold">n</content>
</td>
<td stylecode="Toprule Lrule">
<content stylecode="bold">AUC % (95% CI)</content>
</td>
<td stylecode="Toprule Lrule">
<content stylecode="bold">C</content>
<content stylecode="bold">
<sub>max</sub>
</content>
<content stylecode="bold"> (95% CI)</content>
</td>
<td stylecode="Toprule Lrule">
<content stylecode="bold">C</content>
<content stylecode="bold">
<sub>min</sub>
</content>
<content stylecode="bold"> (95% CI)</content>
</td>
</tr>
<tr>
<td stylecode="Toprule Lrule">Alprazolam</td>
<td stylecode="Toprule Lrule">1, single dose</td>
<td stylecode="Toprule Lrule" valign="top">500 q12h, 10 d</td>
<td stylecode="Toprule Lrule" valign="top">12</td>
<td stylecode="Toprule Lrule" valign="top">↓ 12% (-5, 30%)</td>
<td stylecode="Toprule Lrule" valign="top">↓ 16% (5, 27%)</td>
<td stylecode="Toprule Lrule" valign="top">ND</td>
</tr>
<tr>
<td stylecode="Toprule Lrule">Avanafil</td>
<td stylecode="Toprule Lrule">50, single dose</td>
<td stylecode="Toprule Lrule" valign="top">600 q12h</td>
<td stylecode="Toprule Lrule" valign="top">14<sup>6</sup>
</td>
<td stylecode="Toprule Lrule" valign="top">↑ 13-fold</td>
<td stylecode="Toprule Lrule" valign="top">↑ 2.4-fold</td>
<td stylecode="Toprule Lrule" valign="top">ND</td>
</tr>
<tr>
<td stylecode="Toprule Lrule" valign="top">Clarithromycin<br/>
<br/>14-OH clarithromycin<br/> metabolite</td>
<td stylecode="Toprule Lrule" valign="top">500 q12h, 4 d</td>
<td stylecode="Toprule Lrule" valign="top">200 q8h, 4 d</td>
<td stylecode="Toprule Lrule" valign="top">22</td>
<td stylecode="Toprule Lrule" valign="top">↑ 77% (56, 103%)<br/>
<br/>↓ 100% </td>
<td stylecode="Toprule Lrule" valign="top">↑ 31% (15, 51%)<br/>
<br/>↓ 99%</td>
<td stylecode="Toprule Lrule" valign="top">↑ 2.8-fold (2.4, 3.3X)<br/>
<br/>↓ 100%</td>
</tr>
<tr valign="top">
<td stylecode="Toprule Lrule">Desipramine<br/>
<br/>2-OH desipramine<br/> metabolite </td>
<td stylecode="Toprule Lrule">100, single dose</td>
<td stylecode="Toprule Lrule">500 q12h, 12 d</td>
<td stylecode="Toprule Lrule">14</td>
<td stylecode="Toprule Lrule">↑ 145% (103, 211%)<br/>
<br/>↓ 15% (3, 26%)</td>
<td stylecode="Toprule Lrule">↑ 22% (12, 35%)<br/>
<br/>↓ 67% (62, 72%)</td>
<td stylecode="Toprule Lrule">ND<br/>
<br/>ND</td>
</tr>
<tr>
<td stylecode="Toprule Lrule">Didanosine</td>
<td stylecode="Toprule Lrule">200 q12h, 4 d</td>
<td stylecode="Toprule Lrule">600 q12h, 4 d</td>
<td stylecode="Toprule Lrule">12</td>
<td stylecode="Toprule Lrule">↓ 13% (0, 23%)</td>
<td stylecode="Toprule Lrule">↓ 16% (5, 26%)</td>
<td stylecode="Toprule Lrule">↔</td>
</tr>
<tr>
<td stylecode="Toprule Lrule">Ethinyl estradiol</td>
<td stylecode="Toprule Lrule">50 µg single dose</td>
<td stylecode="Toprule Lrule">500 q12h, 16 d</td>
<td stylecode="Toprule Lrule">23</td>
<td stylecode="Toprule Lrule">↓ 40% (31, 49%)</td>
<td stylecode="Toprule Lrule">↓ 32% (24, 39%)</td>
<td stylecode="Toprule Lrule">ND</td>
</tr>
<tr>
<td stylecode="Toprule Lrule">Fluticasone propionate aqueous nasal spray</td>
<td stylecode="Toprule Lrule" valign="top">200 mcg qd, 7 d</td>
<td stylecode="Toprule Lrule" valign="top">100 mg q12h, 7 d</td>
<td stylecode="Toprule Lrule" valign="top">18</td>
<td stylecode="Toprule Lrule" valign="top">↑ approximately 350-fold<sup>5</sup>
</td>
<td stylecode="Toprule Lrule" valign="top">↑ approximately 25-fold<sup>5</sup>
</td>
<td stylecode="Toprule Lrule"> </td>
</tr>
<tr valign="top">
<td stylecode="Toprule Lrule">Indinavir<sup>1</sup>
<br/>Day 14<br/>Day 15</td>
<td stylecode="Toprule Lrule">400 q12h, 15 d</td>
<td stylecode="Toprule Lrule">400 q12h, 15 d</td>
<td stylecode="Toprule Lrule">10</td>
<td stylecode="Toprule Lrule">
<br/>↑ 6% (-14, 29%)<br/>↓ 7% (-22, 28%)</td>
<td stylecode="Toprule Lrule">
<br/>↓ 51% (40, 61%)<br/>↓ 62% (52, 70%) </td>
<td stylecode="Toprule Lrule">↑ 4-fold (2.8, 6.8X)<br/>↑ 4-fold (2.5, 6.5X) </td>
</tr>
<tr valign="top">
<td stylecode="Toprule Lrule">Ketoconazole</td>
<td stylecode="Toprule Lrule">200 daily, 7 d</td>
<td stylecode="Toprule Lrule">500 q12h, 10 d</td>
<td stylecode="Toprule Lrule">12</td>
<td stylecode="Toprule Lrule">↑ 3.4-fold (2.8, 4.3X)</td>
<td stylecode="Toprule Lrule">↑ 55% (40, 72%)</td>
<td stylecode="Toprule Lrule">ND</td>
</tr>
<tr valign="top">
<td stylecode="Toprule Lrule">Meperidine <br/>
<br/>Normeperidine metabolite</td>
<td stylecode="Toprule Lrule">50 oral single dose</td>
<td stylecode="Toprule Lrule">500 q12h, 10 d</td>
<td stylecode="Toprule Lrule">8<br/>
<br/>6</td>
<td stylecode="Toprule Lrule">↓ 62% (59, 65%)<br/>
<br/>↑ 47% (-24, 345%)</td>
<td stylecode="Toprule Lrule">↓ 59% (42, 72%)<br/>
<br/>↑ 87% (42, 147%) </td>
<td stylecode="Toprule Lrule">ND<br/>
<br/>ND</td>
</tr>
<tr valign="top">
<td stylecode="Toprule Lrule">Methadone<sup>2</sup>
</td>
<td stylecode="Toprule Lrule">5, single dose</td>
<td stylecode="Toprule Lrule">500 q12h, 15 d</td>
<td stylecode="Toprule Lrule">11</td>
<td stylecode="Toprule Lrule">↓ 36% (16, 52%)</td>
<td stylecode="Toprule Lrule">↓ 38% (28, 46%)</td>
<td stylecode="Toprule Lrule">ND</td>
</tr>
<tr>
<td align="left" stylecode="Toprule Lrule" valign="top">Raltegravir</td>
<td align="left" stylecode="Toprule Lrule" valign="top">400, single dose</td>
<td align="left" stylecode="Toprule Lrule" valign="top">100 q12h, 16 d</td>
<td align="left" stylecode="Toprule Lrule" valign="top">10</td>
<td align="left" stylecode="Toprule Lrule" valign="top">↓ 16% (-30, 1%)</td>
<td align="left" stylecode="Toprule Lrule" valign="top">↓ 24% (-45, 4%)</td>
<td align="left" stylecode="Toprule Lrule" valign="top">↓ 1% (-30, 40%)</td>
</tr>
<tr>
<td align="left" stylecode="Toprule Lrule" valign="top">Rivaroxaban</td>
<td align="left" stylecode="Toprule Lrule" valign="top">10, single dose <br/>(days 0 and 7)</td>
<td stylecode="Toprule Lrule">600 q12h <br/>(days 2 to 7)</td>
<td align="left" stylecode="Toprule Lrule" valign="top">12</td>
<td align="left" stylecode="Toprule Lrule" valign="top">↑ 150% (130-<br/>170%)<sup>7</sup>
</td>
<td stylecode="Toprule Lrule">↑ 60% (40-<br/>70%)<sup>7</sup>
</td>
<td align="left" stylecode="Toprule Lrule" valign="top">ND</td>
</tr>
<tr valign="top">
<td stylecode="Toprule Lrule">Rifabutin<br/>25-<content stylecode="italics">O</content>-desacetyl rifabutin metabolite</td>
<td stylecode="Toprule Lrule">150 daily, 16 d</td>
<td stylecode="Toprule Lrule">500 q12h, 10 d</td>
<td stylecode="Toprule Lrule">5,<br/>
<br/>
<br/>11* </td>
<td stylecode="Toprule Lrule">↑ 4-fold (2.8, 6.1X)<br/>
<br/>↑ 38-fold (28, 56X) </td>
<td stylecode="Toprule Lrule">↑ 2.5-fold (1.9, 3.4X)<br/>
<br/>↑ 16-fold (13, 20X)</td>
<td stylecode="Toprule Lrule">↑ 6-fold (3.5, 18.3X)<br/>
<br/>↑ 181-fold (ND)</td>
</tr>
<tr>
<td stylecode="Toprule Lrule">Sildenafil</td>
<td stylecode="Toprule Lrule">100, single dose</td>
<td stylecode="Toprule Lrule">500 twice daily, 8 d</td>
<td stylecode="Toprule Lrule">28</td>
<td stylecode="Toprule Lrule">↑ 11-fold</td>
<td stylecode="Toprule Lrule">↑ 4-fold</td>
<td stylecode="Toprule Lrule">ND</td>
</tr>
<tr>
<td stylecode="Toprule Lrule">Simeprevir</td>
<td stylecode="Toprule Lrule">200 mg qd, 7 d</td>
<td stylecode="Toprule Lrule">100 mg bid, 15 d</td>
<td stylecode="Toprule Lrule">12</td>
<td stylecode="Toprule Lrule">↑ 618% (463%-815%)<sup>8</sup>
</td>
<td stylecode="Toprule Lrule">↑370% (284%-476%)<sup>8</sup>
</td>
<td stylecode="Toprule Lrule">↑1335% (929%-1901%)<sup>8</sup>
</td>
</tr>
<tr>
<td stylecode="Toprule Lrule">Sulfamethoxazole<sup>3</sup>
</td>
<td stylecode="Toprule Lrule">800, single dose</td>
<td stylecode="Toprule Lrule">500 q12h, 12 d</td>
<td stylecode="Toprule Lrule">15</td>
<td stylecode="Toprule Lrule">↓ 20% (16, 23%)</td>
<td stylecode="Toprule Lrule">↔</td>
<td stylecode="Toprule Lrule">ND</td>
</tr>
<tr>
<td stylecode="Toprule Lrule">Tadalafil</td>
<td stylecode="Toprule Lrule">20 mg, single dose</td>
<td stylecode="Toprule Lrule">200 mg q12h</td>
<td stylecode="Toprule Lrule"> </td>
<td stylecode="Toprule Lrule">↑ 124%</td>
<td stylecode="Toprule Lrule">↔</td>
<td stylecode="Toprule Lrule">ND</td>
</tr>
<tr valign="top">
<td stylecode="Toprule Lrule">Theophylline</td>
<td stylecode="Toprule Lrule">3 mg/kg q8h, 15 d</td>
<td stylecode="Toprule Lrule">500 q12h, 10 d</td>
<td stylecode="Toprule Lrule">13, 11*</td>
<td stylecode="Toprule Lrule">↓ 43% (42, 45%)</td>
<td stylecode="Toprule Lrule">↓ 32% (29, 34%)</td>
<td stylecode="Toprule Lrule">↓ 57% (55, 59%)</td>
</tr>
<tr valign="top">
<td stylecode="Toprule Lrule">Trazodone</td>
<td stylecode="Toprule Lrule">50 mg, single dose</td>
<td stylecode="Toprule Lrule">200 mg q12h, 4 doses</td>
<td stylecode="Toprule Lrule">10</td>
<td stylecode="Toprule Lrule">↑ 2.4-fold</td>
<td stylecode="Toprule Lrule">↑ 34%</td>
<td> </td>
</tr>
<tr valign="top">
<td stylecode="Toprule Lrule">Trimethoprim<sup>3</sup>
</td>
<td stylecode="Toprule Lrule">160, single dose</td>
<td stylecode="Toprule Lrule">500 q12h, 12 d</td>
<td stylecode="Toprule Lrule">15</td>
<td stylecode="Toprule Lrule">↑ 20% (3, 43%)</td>
<td stylecode="Toprule Lrule">↔</td>
<td stylecode="Toprule Lrule">ND</td>
</tr>
<tr>
<td stylecode="Toprule Lrule">Vardenafil</td>
<td stylecode="Toprule Lrule">5 mg</td>
<td stylecode="Toprule Lrule">600 q12h</td>
<td stylecode="Toprule Lrule"> </td>
<td stylecode="Toprule Lrule">↑ 49-fold</td>
<td stylecode="Toprule Lrule">↑ 13-fold</td>
<td stylecode="Toprule Lrule">ND</td>
</tr>
<tr valign="top">
<td stylecode="Toprule Lrule">Voriconazole</td>
<td stylecode="Toprule Lrule">400 q12h, 1 d; then 200 q12h, 8 d</td>
<td stylecode="Toprule Lrule">400 q12h, 9 d</td>
<td stylecode="Toprule Lrule"> </td>
<td stylecode="Toprule Lrule">↓ 82%</td>
<td stylecode="Toprule Lrule">↓ 66%</td>
<td stylecode="Toprule Lrule"> </td>
</tr>
<tr>
<td stylecode="Toprule Lrule" valign="top"> </td>
<td stylecode="Toprule Lrule" valign="top">400 q12h, 1 d; then 200 q12h, 8 d</td>
<td stylecode="Toprule Lrule" valign="top">100 q12h, 9 d</td>
<td stylecode="Toprule Lrule" valign="top"> </td>
<td stylecode="Toprule Lrule" valign="top">↓ 39%</td>
<td stylecode="Toprule Lrule" valign="top">↓ 24%</td>
<td stylecode="Toprule Lrule" valign="top"> </td>
</tr>
<tr valign="top">
<td stylecode="Toprule Lrule">Warfarin<br/>S-Warfarin <br/>R-Warfarin</td>
<td stylecode="Toprule Lrule">5, single dose</td>
<td stylecode="Toprule Lrule">400 q12h, 12d</td>
<td stylecode="Toprule Lrule">12</td>
<td stylecode="Toprule Lrule">
<br/>↑ 9% (-17, 44%)<sup>4</sup>
<br/>↓ 33% (-38, -27%)<sup>4</sup>
</td>
<td stylecode="Toprule Lrule">
<br/>↓ 9% (-16, -2%)<sup>4</sup>
<br/>↔ </td>
<td stylecode="Toprule Lrule">
<br/>ND<br/>
<br/>ND</td>
</tr>
<tr valign="top">
<td stylecode="Toprule Lrule">Zidovudine</td>
<td stylecode="Toprule Lrule">200 q8h, 4 d</td>
<td stylecode="Toprule Lrule">300 q6h, 4 d</td>
<td stylecode="Toprule Lrule">9</td>
<td stylecode="Toprule Lrule">↓ 25% (15, 34%)</td>
<td stylecode="Toprule Lrule">↓ 27% (4, 45%)</td>
<td stylecode="Toprule Lrule">ND</td>
</tr>
</tbody>
</table>